You are here

  • Home
  • Archive
  • Volume 4, Issue 2
  • Correction: Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial

Article metrics

Article menu

See original article:

Download PDFPDF

Correction
Correction: Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial

 

Online download statistics by month:

Online download statistics by month: September 2018 to August 2024

AbstractFullPdf
Sep 201833033074
Oct 201812512520
Nov 2018686824
Dec 2018454514
Jan 201949479
Feb 2019666212
Mar 2019595410
Apr 201939377
May 201918186
Jun 2019191811
Jul 201911114
Aug 201915156
Sep 201920188
Oct 2019242211
Nov 201914137
Dec 2019882
Jan 202022205
Feb 202013123
Mar 202011106
Apr 202018164
May 202015147
Jun 2020181710
Jul 202014143
Aug 2020552
Sep 202017145
Oct 2020282810
Nov 202012123
Dec 2020883
Jan 202117167
Feb 202110106
Mar 202111114
Apr 2021161612
May 2021887
Jun 202113132
Jul 2021779
Aug 2021101014
Sep 20219811
Oct 20219923
Nov 20219916
Dec 2021990
Jan 2022884
Feb 20229104
Mar 202214146
Apr 20221086
May 202226268
Jun 202228286
Jul 202212111
Aug 202227276
Sep 202218179
Oct 202218186
Nov 202210106
Dec 2022771
Jan 20237910
Feb 202320202
Mar 2023562
Apr 2023663
May 2023447
Jun 2023884
Jul 2023666
Aug 2023667
Sep 20236711
Oct 2023330
Nov 202315155
Dec 2023882
Jan 2024771
Feb 202410100
Mar 202410104
Apr 202412127
May 202415154
Jun 202417155
Jul 202423217
Aug 20241194
Total16051568551